For Immediate Release


Yvonne M. Psaila

Director, Marketing & Communications

Keystone Symposia on Molecular & Cellular Biology

+ 1 970-262-2676



Keystone Symposia Convenes Virtual ePanel on Tech Transfer on February 14, 2018


SILVERTHORNE, CO – February 6, 2018 – Keystone Symposia is pleased to announce that it will host a free ePanel discussion on the topic of “Tech Transfer for Medical Advances: Challenges and Opportunities in Commercializing Academic Biomedical Research” on February 14, 2018 at 12:00 PM ET. The 90-minute event will be broadcast globally and will include a 30-minute audience Q&A session. The event is open to everyone with online registration required at Audience members can submit a question for the panel when they register or during the event broadcast via the chat room.


The panel will be moderated by Dr. Juan Carlos Lopez, formerly editor of Nature Medicine and Nature Reviews Neuroscience, then Head of Academic Relations and Collaborations at Roche, and now founder and president of Haystack Science. Panelists consist of Lita Nelsen, recently retired from her position for 30 years as the Director of Technology Licensing Office at the Massachusetts Institute of Technology; Dr. Curtis Keith; Chief Scientific Officer of Harvard University’s Blavatnik Biomedical Accelerator; Dr. Katherine Bowdish, Head of Sanofi’s Sunrise Ventures; and Dr. Avi D. Spier, Director of Business Development and Licensing at Novartis Institutes for BioMedical Research.


Drawing on the panel’s expertise from both sides of the table, pharma and academia, the discussion will focus on keys to success as well as obstacles in the process of translating basic research discoveries into therapies that can improve health and patients’ lives. According to Dr. Lopez, “Factors ranging from too much secrecy and confidentiality to unrealistic expectations of pay-offs and timelines can impede academic-industry collaborations in biomedical research. The panelists will share their own experiences and advice to break down some of these barriers.”



About Virtual Keystone Symposia


Keystone Symposia’s new “Virtual Keystone Symposia” format is a way to hold short symposia and panel discussions on timely topics that can benefit from an accelerated production schedule. The format also serves as a way to share the scientific insights gained with a more extensive global audience than those who can attend face-to-face conferences. To date since this new programming model was launched about four years ago, more than 6,000 people have participated in Virtual Keystone Symposia events, which have been held on diverse topics including neuroscience, genome editing, noncoding RNAs, malaria, multiple sclerosis, neuroinflammation and reproducibility in science. All events are available to view in archived form at In addition to virtual events, this site also houses a number of scientific video talks filmed at various Keystone Symposia conferences.




About Keystone Symposia on Molecular and Cellular Biology


Keystone Symposia on Molecular and Cellular Biology, a 501(c)(3) nonprofit organization, has been conducting internationally renowned, open scientific conferences since its founding as UCLA Symposia in 1972 and has been headquartered in Summit County, Colorado, USA since 1990.


It will convene 60 face-to-face conferences in the 2017-2018 season, the majority of which will take place between January and April 2018, on topics ranging from cancer and immunology to neuroscience and genomics. Registration fees are supplemented by generous financial support from corporate, foundation and individual donors as well as government grants.


More information about the organization and its meetings is located at and, respectively. To register for the tech transfer event, visit and to watch a brief video preview of it, visit